# Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury

> **NCT01210456** · PHASE3 · UNKNOWN · sponsor: **Tokushukai Medical Group** · enrollment: 458 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Physiological Saline, N-Acetylcysteine and Sodium Bicarbonate

## Key facts

- **NCT ID:** NCT01210456
- **Lead sponsor:** Tokushukai Medical Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 458 (ESTIMATED)
- **Last updated:** 2014-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210456, "Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01210456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*